This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now
by Zacks Equity Research
McKesson's oncology growth, GLP-1 momentum and RxTS expansion support earnings strength, but pricing reform and margin pressures pose risks.
MCKNegative Net Change GMEDPositive Net Change PACBNegative Net Change BDSXNegative Net Change
medical medical-devices
BD Launches Elyra Thulium Fiber Laser System for Kidney Stone Care
by Zacks Equity Research
BDX launches the Elyra Thulium Fiber Laser system to streamline kidney stone care and boost workflow flexibility for urology teams.
BDXPositive Net Change ISRGNegative Net Change WSTPositive Net Change GMEDPositive Net Change
medical medical-devices
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
by Zacks Equity Research
INGN broadens beyond portable oxygen concentrators into home respiratory care, but U.S. revenues face pressure from channel shifts.
ISRGNegative Net Change WSTPositive Net Change GMEDPositive Net Change INGNNegative Net Change
medical medical-devices
MMED's Latest Study Supports the Strength of 780G SmartGuard Algorithm
by Zacks Equity Research
MiniMed study results show MiniMed 780G delivering consistent glycemic outcomes across sensors, reinforcing SmartGuard's strength.
GMEDPositive Net Change PACBNegative Net Change BDSXNegative Net Change MMEDPositive Net Change
medical medical-devices
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth
by Zacks Equity Research
PRPO's first-quarter 2026 sales are driven by pathology momentum, but CMS reimbursement cuts and higher spending squeeze margins and widen losses.
PRPONegative Net Change
earnings medical medical-devices
Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical
by Zacks Equity Research
ELMD, GMED and ISRG are leveraging GenAI, strong procedure growth and expanding markets as healthcare AI adoption accelerates.
ISRGNegative Net Change ELMDNegative Net Change GMEDPositive Net Change
medical-devices
Should You Continue to Hold Labcorp Stock in Your Portfolio?
by Zacks Equity Research
LH gains from specialty testing growth, acquisitions and AI initiatives, but currency swings and macro pressures remain risks.
LHPositive Net Change ALGNPositive Net Change IARTNegative Net Change GMEDPositive Net Change
medical medical-devices
TBRG Posts Q1 Earnings: How to Play the Stock Amid Pending Sell-off?
by Moumi Mondal
TruBridge climbs after Q1 EPS beats estimates and an IKS Health buyout deal sets a $26.25-per-share cash offer for shareholders.
MCKNegative Net Change TBRGPositive Net Change WAYPositive Net Change
medical medical-devices
Should You Buy Omnicell (OMCL) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
OMCLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Ralliant (RAL) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RALPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines